Who Owns Rhythm Pharmaceuticals Stock?
NASDAQ: RYTMHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Ownership breakdown
- Held by institutions
- 116.56%
- Institutions (% of float)
- 117.85%
- Held by insiders
- 1.10%
- Institutional holders
- 454
- Institutions 98.9%
- Insiders 1.1%
- Public and other 0.0%
Who owns Rhythm Pharmaceuticals stock?
Institutional investors own about 116.6% of Rhythm Pharmaceuticals's shares, spread across 454 institutions that file 13F reports. That level of institutional ownership is high, typical of large, widely followed companies. Insiders, including executives, directors and large founding shareholders, hold 1.10% of RYTM.
The largest institutional holders are RA Capital Management, L.P. (9.62%), Blackrock Inc. (8.62%) and Baker Bros. Advisors, LP (8.08%). Together, the top 10 institutions control 56.0% of shares outstanding. In their latest filings, 5 of the top 10 institutions increased their RYTM positions and 3 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of RYTM
| Institution | Shares | % Held | Change |
|---|---|---|---|
| RA Capital Management, L.P. | 6.67M | 9.62% | 0.0% |
| Blackrock Inc. | 5.98M | 8.62% | -3.0% |
| Baker Bros. Advisors, LP | 5.60M | 8.08% | 0.0% |
| JPMORGAN CHASE & CO | 3.56M | 5.13% | +34.1% |
| Vanguard Portfolio Management LLC | 3.15M | 4.54% | +0.4% |
| Primecap Management Company | 3.06M | 4.42% | -3.3% |
| Vanguard Capital Management LLC | 3.01M | 4.33% | -0.0% |
| State Street Corporation | 2.64M | 3.81% | +2.5% |
| Perceptive Advisors Llc | 2.59M | 3.73% | +8.9% |
| Price (T.Rowe) Associates Inc | 2.57M | 3.70% | +55.1% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of RYTM
| Fund | Shares | % Held |
|---|---|---|
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 2.18M | 3.14% |
| PRIMECAP Odyssey Funds-PRIMECAP Odyssey Aggressive Growth Fund | 1.94M | 2.79% |
| SmallCap World Fund Inc | 1.77M | 2.55% |
| VANGUARD INDEX FUNDS-Vanguard Small-Cap Index Fund | 1.57M | 2.27% |
| iShares Trust-iShares Russell 2000 ETF | 1.50M | 2.16% |
| SPDR SERIES TRUST-State Street SPDR S&P Biotech ETF | 1.18M | 1.71% |
| Federated Hermes Equity Funds-Federated Hermes Kaufmann Fund | 1.03M | 1.48% |
| PRIMECAP Odyssey Funds-PRIMECAP Odyssey Growth Fund | 952.10K | 1.37% |
| VANGUARD INDEX FUNDS-Vanguard Small-Cap Growth Index Fund | 906.00K | 1.31% |
| T. Rowe Price New Horizons Fund, Inc. | 779.82K | 1.12% |
Frequently asked questions
Who is the largest shareholder of Rhythm Pharmaceuticals?
RA Capital Management, L.P. is the largest institutional shareholder of RYTM, owning 9.62% of shares outstanding (6.67M shares) as of its latest 13F filing.
What percentage of Rhythm Pharmaceuticals is owned by institutions?
Institutions own about 116.6% of RYTM shares and 117.9% of the public float.
How much of Rhythm Pharmaceuticals do insiders own?
Insiders, such as officers and directors, own about 1.10% of RYTM shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.